Table 1. Oldest-old BSHRI Study Subject Data.
| ND-HPC | Expired age (y) | Gender | PMI (h) | Brain Weight (g) | Last MMSE score | ApoE GT | Total plaque score | Total tangle score | Braak stage | Total WMR score | Total CAA score |
| 1 | 91 | M | 3.0 | 1050 | - | 3/4 | 10.75 | 5 | III | 0 | 0 |
| 2 | 100 | M | 2.5 | 1160 | 29 | 3/3 | 14 | 8 | IV | 1 | 8 |
| 3 | 90 | F | 4.3 | 975 | 28 | 3/3 | 10.5 | 5 | III | 1 | 0 |
| 4 | 94 | M | 3.5 | 1100 | 27 | 3/3 | 15 | 10.5 | IV | 10 | 9 |
| 5 | 90 | F | 2.5 | 966 | 25 | 3/3 | 13.5 | 8 | IV | 2 | 1 |
| 6 | 92 | M | 3.2 | 1300 | 27 | 2/4 | 14 | 12 | V | 1 | 8 |
| 7 | 91 | M | 4.3 | 1150 | 29 | 2/3 | 14.5 | 8.5 | IV | 1 | 1 |
| 8 | 94 | M | 2.5 | 1050 | 29 | 3/3 | 15 | 12 | IV | 2 | 1 |
| Mean | 92.8 | 3.2 | 1094 | 27.7 | 13.4 | 8.6 | 2.3 | 3.5 |
ND-HPC = non-demented high pathology controls; AD = Alzheimer's disease; y = years; M = male; F = female; PMI = postmortem interval; h = hours; g = grams; MMSE = mini-mental state examination; ApoE = apolipoprotein E; GT = genotype; WMR = white matter rarefaction; CAA = cerebral amyloid angiopathy.